Project Details
Description
An observational long-term safety and efficacy followup study after ex-vivo gene therapy with BIVV003 in participants with severe sickle cell disease (SCD) or with ST-400 in participants with transfusion-dependent ??-thalassemia (TDT) with autologous hem
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/22 → 7/31/26 |
Funding
- SANOFI-AVENTIS US
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.